Pages that link to "Q22241837"
Jump to navigation
Jump to search
The following pages link to Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development (Q22241837):
Displaying 25 items.
- Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review (Q26782993) (← links)
- Pharmacological approaches to the challenge of treatment-resistant depression (Q26798241) (← links)
- 1H-NMR, 1H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling (Q33760065) (← links)
- Treatment of mitochondrial disorders. (Q33794684) (← links)
- Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder (Q34113404) (← links)
- Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach (Q34268501) (← links)
- Sex-specific urinary biomarkers for diagnosing bipolar disorder (Q34757521) (← links)
- DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions (Q35042639) (← links)
- Calcium-dependent intracellular signal pathways in primary cultured adipocytes and ANK3 gene variation in patients with bipolar disorder and healthy controls. (Q36863531) (← links)
- Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder. (Q37200180) (← links)
- Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention (Q37705451) (← links)
- Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy (Q38086474) (← links)
- Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications (Q38114007) (← links)
- Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications. (Q38154840) (← links)
- A mitochondrial bioenergetic basis of depression (Q38254909) (← links)
- Biological hypotheses and biomarkers of bipolar disorder (Q38995726) (← links)
- Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder (Q39145749) (← links)
- N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons (Q39165434) (← links)
- Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression (Q39431425) (← links)
- Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease (Q45290056) (← links)
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression (Q47695444) (← links)
- Endogenous cardiac steroids in animal models of mania (Q48049414) (← links)
- Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression (Q48195966) (← links)
- Mitochondrial Agents for Bipolar Disorder (Q52621890) (← links)
- Na⁺, K⁺-ATPase Signaling and Bipolar Disorder (Q58796804) (← links)